The
Blood Collection market industry is projected to grow from USD 4.806 Billion in
2023 to USD 8.134929 billion by 2032, exhibiting a compound annual growth rate
(CAGR) of 6.80% during the forecast period (2023 - 2032).
The
blood collection market continues its steady growth trajectory,
driven by increasing demand for diagnostic procedures, rising prevalence of
chronic diseases, and expanding geriatric populations globally. With
technological advancements, automated blood collection devices are gaining
traction for efficiency and safety. Moreover, the COVID-19 pandemic has
underscored the importance of blood testing for surveillance and treatment
monitoring, further stimulating market growth. Innovations in needle designs,
safety features, and specimen collection techniques enhance patient comfort and
healthcare worker safety. Emerging economies present lucrative opportunities
for market players, fueling investments in infrastructure and healthcare
facilities. Overall, the blood collection market is poised for sustained
expansion amid evolving healthcare landscapes.
The
Blood Collection Market encompasses a vital aspect of healthcare
infrastructure, facilitating various medical procedures, diagnostics, and
research endeavors. Among its key components are cord blood banking and blood
collection tubes, each serving distinct yet interconnected purposes.
Cord blood banking involves the collection and preservation
of umbilical cord blood, which contains valuable stem cells. These stem cells
have the potential to treat numerous diseases and disorders, making cord blood
banking a critical resource for both current and future medical treatments. As
medical advancements progress, the demand for cord blood banking services
continues to rise, driving growth within the blood collection market.
Blood
collection tubes play an equally essential role in healthcare diagnostics and
research. These tubes enable the safe and efficient collection, storage, and
transportation of blood samples for various laboratory analyses. With
advancements in technology, blood collection tubes now come in diverse types
optimized for different testing requirements, ensuring accurate and reliable
results across various medical settings.
The
synergy between cord blood banking and blood collection tubes underscores the
dynamic nature of the blood collection market. As healthcare systems worldwide
emphasize the importance of personalized medicine and regenerative therapies,
the demand for both cord blood banking and advanced blood collection
technologies is expected to surge, driving innovation and expansion within the
market landscape. This growth presents opportunities for stakeholders to
collaborate, innovate, and address evolving healthcare needs effectively.
Segmentation
The
global blood collection market has been segmented based on type of blood collection, product, method, and
end user.
By type
of blood collection, the global blood collection market has been segmented into
capillary blood collection, venous blood collection, and vacuum blood
collection.
By
product, the global blood collection market has been segmented into blood
collection devices, blood collection tubes and collector, needles and syringes,
warming devices, blood bags, lancets, and others. The blood collection tubes
and collector segment has been further segmented into serum collection tubes,
and plasma or whole blood collection tubes. The plasma or whole blood
collection tubes sub-segment has been further segmented into EDTA tubes,
heparin tubes, coagulation tubes, glucose tubes, and ESR tubes.
By method, the global blood collection market has
been segmented into automated blood collection and manual blood collection.
By end
user, the global blood collection market has been segmented into hospitals
& clinics, diagnostic centers and
pathology laboratories, home diagnostics, blood banks, and others. The
hospitals & clinics segment accounts for the largest share of the market
share due to the growing burden of
chronic diseases. The diagnostic centers
and pathology laboratories segment is likely to capture the highest CAGR owing
to the ongoing research on better blood sampling approaches.
Competitive Landscape
The global blood
collection companies include Thermo Fisher Scientific Inc.,Nipro Medical,
Kawasumi Laboratories, Haemonetics, F.L. Medical, Sarstedt AG & Co,
Grifols,Terumo, B. Braun Melsungen AG, Medtronic, Fresenius, Greiner Holding,
HTL-STREFA S.A., and BD.
Regional Analysis
The Americas, Asia Pacific (APAC), Europe, and the Middle East
& Africa (MEA) are the key markets for blood collection.
The Americas dominate the global blood collection market on
account of the rising prevalence of
chronic diseases which necessitates blood tests to be performed for diagnosis
and treatment. High healthcare expenditure and improvement in blood collection
methods and devices also favor market
growth.
Europe follows the Americas closely and accounts for the second
largest share of the global blood collection market. Rigorous R&D
activities and government funding for the same propels the market in Europe. In
addition, the growing presence of leading
market players in the region acts as a plus for the growth of the market.
APAC is poised to exhibit the highest growth rate over the
forecast period. Presence of a massive patient pool and improvement in
healthcare infrastructure drive the market in APAC.
Related Reports:
Clinical Trial Management System
Alzheimer’s disease Diagnostics
For More
Information, Please Visit @ Market
Research Future
0 Comments